Our view: Unemployment insurance fund needs to be fixed
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Farmers and ranchers struggle to get products to market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Tri-county businesses grapple with COVID-19 legal liability issues
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Dubroff: COVID-19 kills Garman’s Pub in Santa Paula
For Santa Paula entrepreneur Clint Garman, the eponymous tavern he ran for more than a decade was never about the Guinness he poured or the happy hour specials he served. It was, he told me, “about bringing people of all cultures together under one roof. About bringing conversation back to the table.” With conversations muted Read More →
Read More →Tri-Counties start to reopen closed parts of the region’s economy
California is reopening some previously-closed establishments, but what that actually looks like will depend on the county — and in some places, the city — where people live. San Luis Obispo, Santa Barbara and Ventura counties are all taking different approaches as they figure out how to best protect their populations while allowing some parts Read More →
Read More →Amgen’s Otezla could be treatment for COVID-19
Amgen’s newly acquired Otezla product line could find a role in a suite of new therapies designed to treat COVID-19 patients. News of the potential for the rheumatoid arthritis product came as the Thousand Oaks-based biotech reported that earnings and revenue shot up in the first quarter. The company’s outlook stayed flat as it shifts Read More →
Read More →MannKind beats earnings estimates
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Sponsored content:
2015-2016 Giving Guide
